Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06754150 · ClinicalTrials.gov registry record

Shoulder Innovations Clinical Data Registry

A clinical trial of Shoulder Arthroplasty, sponsored by Shoulder Innovations.

Recruiting
Registry status
2,500
Enrollment target
6
Study locations

NCT06754150 is a study of Shoulder Arthroplasty that is actively recruiting participants, run by Shoulder Innovations. The registered enrollment target is 2,500 participants, above the 606-participant average among 5 other Shoulder Arthroplasty trials with a reported enrollment target (313% higher). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06754150, a study of Shoulder Arthroplasty, is actively recruiting participants, sponsored by Shoulder Innovations.

RECRUITING
Registry status
2,500 participants
Enrollment target
6
Study locations

Study Summary

The goal of this multi-center observational study is to collect long-term clinical outcome information for anatomic and reverse total shoulder arthroplasty (shoulder replacement).

Conditions Studied

Study Locations (6)

Alabama

  • St. Vincent's Orthopedics - Birmingham

California

  • California Pacific Orthopaedics - San Francisco

Colorado

  • Western Orthopaedics - Denver

Florida

  • Connolly Orthopedics - Bradenton

Georgia

  • Georgia Bone and Joint - Newnan

Massachusetts

  • North Shore Physicians Group - Peabody

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2024-10-23
Est. Completion 2039-12

Sponsor

Shoulder Innovations

1 total trials

What the Registry Record Tells You About NCT06754150

The ClinicalTrials.gov registry entry for NCT06754150 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 606-participant average among 5 other Shoulder Arthroplasty trials with a reported enrollment target (313% higher). The listed sponsor is Shoulder Innovations, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Shoulder Arthroplasty appearing as the primary indexed condition, and to 0 interventions.

NCT06754150 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Alabama, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT06754150 about?

NCT06754150 is a clinical study titled "Shoulder Innovations Clinical Data Registry". The goal of this multi-center observational study is to collect long-term clinical outcome information for anatomic and reverse total shoulder arthroplasty (shoulder replacement).

What is the current status of trial NCT06754150?

This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2024-10-23. Estimated completion is 2039-12.

What conditions does trial NCT06754150 study?

This clinical trial studies the following conditions: Shoulder Arthroplasty.

Who is sponsoring clinical trial NCT06754150?

This trial is sponsored by Shoulder Innovations, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06754150 being conducted?

This trial has 6 study locations across Alabama, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.